Press releaseGlobe Newswire
Metagenomi Therapeutics
MGX · NASDAQ
$0.8313+$0.0195 (+2.40%)TodayMarket closed ·
Prev close $0.8118
Latest news
- Press releaseGlobe Newswire
Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
- Press releasePRNewswire
Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- Press releaseGlobe Newswire
Metagenomi Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
- Press releasePRNewswire
Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- Press releaseGlobe Newswire
Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference
- Press releaseGlobe Newswire
Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency
- Press releasePRNewswire
Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- News
Metagenomi Therapeutics Q4 Earnings Assessment
- Press releaseGlobe Newswire
Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results
- Press releaseGlobe Newswire
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference
- Press releaseGlobe Newswire
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook
- Press releaseGlobe Newswire
Metagenomi to Present Preclinical Data Supporting New Collaboration Target of APOC3 with Ionis Pharmaceuticals at Upcoming Nature Conference
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- NewsShomik Sen Bhattacharjee
Sam Altman Says He 'Didn't Think' Elon Musk Would Abuse Government Power, Tesla CEO Hits Back With 'Scam Altman' Jibe
- NewsVandana Singh
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
- News
Demystifying Metagenomi: Insights From 4 Analyst Reviews
- Press releaseGlobe Newswire
Metagenomi to Present at Upcoming Scientific Meetings
- NewsAvi Kapoor
Why Netflix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
- News
Expert Outlook: Metagenomi Through The Eyes Of 4 Analysts
- Press releasePRNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Metagenomi, Inc. - MGX
- Press releasePRNewswire
MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit with the Schall Law Firm
- Press releaseBusiness Wire
FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi
- Press releaseBusiness Wire
MGX Deadline: Rosen Law Firm Urges Metagenomi, Inc. (NASDAQ: MGX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
- Press releasePRNewswire
MGX Deadline: MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Lawsuit
- Press releaseBusiness Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Metagenomi, Inc. (MGX)
- Press releasePRNewswire
The Gross Law Firm Notifies Metagenomi, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - MGX
- Press releasePRNewswire
MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit
- Press releaseGlobe Newswire
Shareholders that lost money on Metagenomi, Inc. (MGX) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More
- Press releasePRNewswire
MGX INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $00,000 In MGX To Contact Him Directly To Discuss Their Options
- Press releasePRNewswire
November 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MGX
- Press releaseGlobe Newswire
Shareholders of Metagenomi, Inc. Should Contact The Gross Law Firm Before November 25, 2024 to Discuss Your Rights – MGX
- Press releaseGlobe Newswire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Metagenomi, Inc. (MGX)
- Press releasePRNewswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Metagenomi, Inc.(MGX) Shareholders
- Press releasePRNewswire
MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit
- Press releaseGlobe Newswire
Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Customers Bancorp, Globus, and Metagenomi and Encourages Investors to Contact the Firm
- News
Peeling Back The Layers: Exploring Metagenomi Through Analyst Insights
- News
Unveiling 4 Analyst Insights On Metagenomi
- Press releaseBusiness Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.